Neoadjuvant SAbR shows promising outcomes in RCC with tumor thrombusByLin Lin, MDDecember 9th 2025Lin Lin, MD, highlights a phase 2 trial of neoadjuvant SAbR followed by surgery in patients with newly diagnosed renal cell carcinoma and caval tumor thrombus.